ABUS logo

Arbutus Biopharma (ABUS) Revenue

Annual revenue:

$6.17M-$11.97M(-65.98%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ABUS annual revenue is $6.17 million, with the most recent change of -$11.97 million (-65.98%) on December 31, 2024.
  • During the last 3 years, ABUS annual revenue has fallen by -$4.82 million (-43.84%).
  • ABUS annual revenue is now -84.18% below its all-time high of $39.02 million, reached on December 31, 2022.

Performance

ABUS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

Quarterly revenue:

$1.76M+$190.00K(+12.07%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ABUS quarterly revenue is $1.76 million, with the most recent change of +$190.00 thousand (+12.07%) on March 31, 2025.
  • Over the past year, ABUS quarterly revenue has increased by +$232.00 thousand (+15.14%).
  • ABUS quarterly revenue is now -87.61% below its all-time high of $14.24 million, reached on June 30, 2022.

Performance

ABUS Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

TTM revenue:

$6.40M+$232.00K(+3.76%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ABUS TTM revenue is $6.40 million, with the most recent change of +$232.00 thousand (+3.76%) on March 31, 2025.
  • Over the past year, ABUS TTM revenue has dropped by -$6.58 million (-50.69%).
  • ABUS TTM revenue is now -83.59% below its all-time high of $39.02 million, reached on December 31, 2022.

Performance

ABUS TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

ABUS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-66.0%+15.1%-50.7%
3 y3 years-43.8%-86.0%-70.2%
5 y5 years+2.7%+18.3%-6.2%

ABUS Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-84.2%at low-87.6%+31.7%-83.6%+3.8%
5 y5-year-84.2%+2.7%-87.6%+31.7%-83.6%+4.2%
alltimeall time-84.2%>+9999.0%-87.6%+1004.6%-83.6%+470.2%

ABUS Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.76M(+12.1%)
$6.40M(+3.8%)
Dec 2024
$6.17M(-66.0%)
$1.57M(+17.6%)
$6.17M(-8.5%)
Sep 2024
-
$1.34M(-22.4%)
$6.74M(-33.0%)
Jun 2024
-
$1.73M(+12.7%)
$10.06M(-22.5%)
Mar 2024
-
$1.53M(-28.6%)
$12.99M(-28.4%)
Dec 2023
$18.14M(-53.5%)
$2.15M(-54.0%)
$18.14M(-18.4%)
Sep 2023
-
$4.66M(+0.2%)
$22.24M(-5.5%)
Jun 2023
-
$4.65M(-30.4%)
$23.54M(-29.0%)
Mar 2023
-
$6.69M(+7.1%)
$33.13M(-15.1%)
Dec 2022
$39.02M(+255.1%)
$6.25M(+4.9%)
$39.02M(+8.4%)
Sep 2022
-
$5.95M(-58.2%)
$35.98M(+7.8%)
Jun 2022
-
$14.24M(+13.2%)
$33.37M(+55.5%)
Mar 2022
-
$12.58M(+292.4%)
$21.46M(+95.3%)
Dec 2021
$10.99M(+58.9%)
$3.21M(-4.0%)
$10.99M(+8.1%)
Sep 2021
-
$3.34M(+43.4%)
$10.17M(+21.8%)
Jun 2021
-
$2.33M(+10.2%)
$8.35M(+10.8%)
Mar 2021
-
$2.11M(-11.4%)
$7.54M(+9.0%)
Dec 2020
$6.91M(+15.0%)
$2.39M(+56.7%)
$6.91M(+12.5%)
Sep 2020
-
$1.52M(+0.6%)
$6.15M(-20.0%)
Jun 2020
-
$1.51M(+1.5%)
$7.68M(+12.6%)
Mar 2020
-
$1.49M(-7.8%)
$6.82M(+13.5%)
Dec 2019
$6.01M(+1.1%)
$1.62M(-47.1%)
$6.01M(-1.0%)
Sep 2019
-
$3.06M(+368.8%)
$6.07M(+32.1%)
Jun 2019
-
$653.00K(-3.8%)
$4.60M(-11.4%)
Mar 2019
-
$679.00K(-59.5%)
$5.19M(-12.7%)
Dec 2018
$5.95M(-44.4%)
$1.68M(+5.7%)
$5.95M(-12.6%)
Sep 2018
-
$1.59M(+27.6%)
$6.80M(-43.8%)
Jun 2018
-
$1.24M(-13.4%)
$12.11M(+1.7%)
Mar 2018
-
$1.44M(-43.3%)
$11.90M(+11.2%)
Dec 2017
$10.70M(+617.6%)
$2.53M(-63.2%)
$10.70M(+34.2%)
Sep 2017
-
$6.89M(+563.3%)
$7.97M(+330.2%)
Jun 2017
-
$1.04M(+342.1%)
$1.85M(+65.0%)
Mar 2017
-
$235.00K(-220.5%)
$1.12M(-24.7%)
Dec 2016
$1.49M(-93.6%)
-$195.00K(-125.2%)
$1.49M(-88.3%)
Sep 2016
-
$774.00K(+150.5%)
$12.78M(-20.5%)
Jun 2016
-
$309.00K(-48.8%)
$16.07M(-16.3%)
Mar 2016
-
$603.00K(-94.6%)
$19.20M(-17.5%)
Dec 2015
$23.28M
$11.09M(+172.8%)
$23.28M(+40.8%)
Sep 2015
-
$4.07M(+18.2%)
$16.54M(-1.8%)
Jun 2015
-
$3.44M(-26.5%)
$16.83M(+10.7%)
DateAnnualQuarterlyTTM
Mar 2015
-
$4.68M(+7.6%)
$15.21M(+1.7%)
Dec 2014
$14.95M(-3.3%)
$4.35M(-0.3%)
$14.95M(-17.5%)
Sep 2014
-
$4.36M(+140.9%)
$18.13M(+8.4%)
Jun 2014
-
$1.81M(-59.1%)
$16.73M(-5.8%)
Mar 2014
-
$4.43M(-41.1%)
$17.76M(+14.9%)
Dec 2013
$15.46M(+9.6%)
$7.53M(+154.0%)
$15.47M(+32.8%)
Sep 2013
-
$2.96M(+4.2%)
$11.65M(-1.1%)
Jun 2013
-
$2.84M(+33.4%)
$11.78M(-5.7%)
Mar 2013
-
$2.13M(-42.5%)
$12.50M(-10.3%)
Dec 2012
$14.11M(-16.1%)
$3.71M(+19.8%)
$13.94M(-4.5%)
Sep 2012
-
$3.10M(-13.0%)
$14.60M(-5.9%)
Jun 2012
-
$3.56M(-0.4%)
$15.51M(-6.0%)
Mar 2012
-
$3.57M(-18.2%)
$16.50M(-5.2%)
Dec 2011
$16.81M(-21.3%)
$4.37M(+9.0%)
$17.40M(-11.6%)
Sep 2011
-
$4.01M(-11.9%)
$19.69M(-23.5%)
Jun 2011
-
$4.55M(+1.8%)
$25.74M(+10.1%)
Mar 2011
-
$4.47M(-32.9%)
$23.38M(+9.6%)
Dec 2010
$21.35M(+55.0%)
$6.66M(-33.8%)
$21.33M(+11.3%)
Sep 2010
-
$10.06M(+357.8%)
$19.16M(+57.5%)
Jun 2010
-
$2.20M(-9.2%)
$12.17M(-8.0%)
Mar 2010
-
$2.42M(-46.1%)
$13.22M(+1.1%)
Dec 2009
$13.78M(+42.9%)
$4.48M(+46.3%)
$13.09M(+29.9%)
Sep 2009
-
$3.07M(-5.8%)
$10.07M(-8.3%)
Jun 2009
-
$3.25M(+42.6%)
$10.99M(+7.6%)
Mar 2009
-
$2.28M(+55.0%)
$10.21M(+4.4%)
Dec 2008
$9.64M(-39.5%)
$1.47M(-63.0%)
$9.79M(-22.3%)
Sep 2008
-
$3.98M(+60.7%)
$12.59M(-12.3%)
Jun 2008
-
$2.48M(+33.7%)
$14.36M(-2.2%)
Mar 2008
-
$1.85M(-56.7%)
$14.68M(+14.4%)
Dec 2007
$15.92M(+17.0%)
$4.28M(-25.6%)
$12.83M(+50.0%)
Sep 2007
-
$5.75M(+105.6%)
$8.55M(+205.6%)
Jun 2007
-
$2.80M
$2.80M
Dec 2006
$13.60M(+2.4%)
-
-
Dec 2005
$13.29M(+9.2%)
-
-
Dec 2004
$12.17M(+345.4%)
-
-
Dec 2003
$2.73M(-46.2%)
-
-
Dec 2002
$5.08M(+63.2%)
-
-
Dec 2001
$3.11M(+6347.4%)
-
-
Dec 2000
$48.30K(-95.8%)
-
-
Dec 1999
$1.14M(-7.1%)
-
-
Dec 1998
$1.23M
-
-

FAQ

  • What is Arbutus Biopharma annual revenue?
  • What is the all time high annual revenue for Arbutus Biopharma?
  • What is Arbutus Biopharma annual revenue year-on-year change?
  • What is Arbutus Biopharma quarterly revenue?
  • What is the all time high quarterly revenue for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly revenue year-on-year change?
  • What is Arbutus Biopharma TTM revenue?
  • What is the all time high TTM revenue for Arbutus Biopharma?
  • What is Arbutus Biopharma TTM revenue year-on-year change?

What is Arbutus Biopharma annual revenue?

The current annual revenue of ABUS is $6.17M

What is the all time high annual revenue for Arbutus Biopharma?

Arbutus Biopharma all-time high annual revenue is $39.02M

What is Arbutus Biopharma annual revenue year-on-year change?

Over the past year, ABUS annual revenue has changed by -$11.97M (-65.98%)

What is Arbutus Biopharma quarterly revenue?

The current quarterly revenue of ABUS is $1.76M

What is the all time high quarterly revenue for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly revenue is $14.24M

What is Arbutus Biopharma quarterly revenue year-on-year change?

Over the past year, ABUS quarterly revenue has changed by +$232.00K (+15.14%)

What is Arbutus Biopharma TTM revenue?

The current TTM revenue of ABUS is $6.40M

What is the all time high TTM revenue for Arbutus Biopharma?

Arbutus Biopharma all-time high TTM revenue is $39.02M

What is Arbutus Biopharma TTM revenue year-on-year change?

Over the past year, ABUS TTM revenue has changed by -$6.58M (-50.69%)
On this page